Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study

Autor: Daniela Gaglio 1, 2, 6, 8, Silvia Valtorta 1, 3, 4, Marilena Ripamonti 1, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1, Sara Belloli 1, Alberto Luini 8, Maria Carla Gilardi 1, Anna Maria Colangelo 2, 9, Lilia Alberghina 2, Rosa Maria Moresco 2

Publikováno v: Oncotarget
Oncotarget 7 (2016): 52017–52031. doi:10.18632/oncotarget.10470
info:cnr-pdr/source/autori:Daniela Gaglio 1,2,6,8, Silvia Valtorta 1,2,3,4, Marilena Ripamonti 1,2, Marcella Bonanomi 2, Chiara Damiani 2, Sergio Todde 5, Alfredo Simone Negri 6, Francesca Sanvito 7, Fabrizia Mastroianni 2, Antonella Di Campli 8, Gabriele Turacchio 8, Giuseppe Di Grigoli 1,2,3, Sara Belloli 1,2,3, Alberto Luini 8, Maria Carla Gilardi 1,2, Anna Maria Colangelo 2,9, Lilia Alberghina 2,9,*, Rosa Maria Moresco 2,3,4,*/titolo:Divergent in vitro%2Fin vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study./doi:10.18632%2Foncotarget.10470/rivista:Oncotarget/anno:2016/pagina_da:52017/pagina_a:52031/intervallo_pagine:52017–52031/volume:7

// Daniela Gaglio 1, 2, 6, 8 , Silvia Valtorta 1, 2, 3, 4 , Marilena Ripamonti 1, 2 , Marcella Bonanomi 2 , Chiara Damiani 2 , Sergio Todde 5 , Alfredo Simone Negri 6 , Francesca Sanvito 7 , Fabrizia Mastroianni 2 , Antonella Di Campli 8 , Gabriele T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208f8a2016f679f3ba7748d6357d2218
http://hdl.handle.net/10281/119849